The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 28, 2017
Filed:
Aug. 04, 2015
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
Xinhua Qian, Flemington, NJ (US);
Keming Zhu, Somerset, NJ (US);
Joerg Deerberg, Columbus, NJ (US);
Wendy Wangying Yang, Plainsboro, NJ (US);
Kana Yamamoto, Toledo, OH (US);
Matthew R. Hickey, Yardley, PA (US);
Assignee:
Bristol-Meyers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 213/77 (2006.01); C07C 35/29 (2006.01); C07D 471/04 (2006.01); C07C 29/00 (2006.01); C07C 51/29 (2006.01); C07C 61/13 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07C 29/00 (2013.01); C07C 35/29 (2013.01); C07C 51/29 (2013.01); C07C 61/13 (2013.01); C07D 213/77 (2013.01); C07C 2102/42 (2013.01);
Abstract
A process is provided for preparing 4-(8-(2-chlorophenoxy)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)bicyclo[2.2.1]heptan-1-ol and novel intermediates used in the process. The compound is a 11-beta hydroxysteroid dehydrogenase type I inhibitor which exhibits activity in the treatment of various metabolic diseases.